Protection of murine foot tissue and transplantable tumor against Photofrin-II-mediated photodynamic sensitization with WR-2721.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Journal of Photochemistry and Photobiology. B: Biology

• Publication date

  1989-11-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/1011-1344(89)80007-7PMID 2556509
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vitro and in vivo protection against phototoxic side effects of photodynamic therapy by radioprotective agents WR-2721 and WR-77913.

  1988cited by this paper
• Prospective study of cutaneous phototoxicity after systemic hematoporphyrin derivative

  1988cited by this paper
• IN VITRO AND IN VIVO PROTECTION AGAINST PHOTOTOXIC SIDE EFFECTS OF PHOTODYNAMIC THERAPY BY RADIOPROTECTIVE AGENTSWR–2721 ANDWR–77913

  1988cited by this paper
• Photodynamic therapy.

  1988cited by this paper
• Radiation protection of murine intestine by WR-2721, 16,16-dimethyl prostaglandin E2, and the combination of both agents.

  1987cited by this paper
• PHOTOSENSITIZERS: THERAPY AND DETECTION OF MALIGNANT TUMORS

  1987cited by this paper
• SKIN PHOTOSENSITIVITY: DURATION and INTENSITY FOLLOWING INTRAVENOUS HEMATOPORPHYRIN DERIVATES, HpD and DHE

  1987cited by this paper
• PHOTOBLEACHING OF PHOTOFRIN II AS A MEANS OF ELIMINATING SKIN PHOTOSENSITIVITY *

  1987cited by this paper
• Photodynamic therapy: The state of the art

  1986cited by this paper
• Comparison of the protective effects of three phosphorothioate radioprotectors in the RIF-1 tumor.

  1986cited by this paper
• Effects of scavengers of reactive oxygen and radical species on cell survival following photodynamic treatment in vitro: comparison to ionizing radiation.

  1986cited by this paper
• Variation in normal tissue responsiveness to WR-2721.

  1984cited by this paper
• Differential radioprotection of normal tissues by hydrophilic chemical protectors.

  1984cited by this paper
• Radioprotection of mouse skin vasculature and the RIF-1 fibrosarcoma by WR-2721.

  1984cited by this paper
• Effect of tumor type, size, and endpoint on tumor radioprotection by WR-2721.

  1984cited by this paper
• HEMATOPORPHYRIN AS A PHOTOSENSITIZER OF TUMORS *

  1983cited by this paper
• Biological Characteristics of Some Improved Radioprotectors

  1980cited by this paper
• Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor.

  1976cited by this paper
• Effect of radioprotective drugs on the therapeutic ratio for a mouse tumor system.

  1973cited by this paper
• Differential chemoprotection of normal and malignant tissues.

  1969cited by this paper
• Chemoprotection against three modes of radiation death in the mouse.

  1969cited by this paper
• Cysteine Protection against X Irradiation.

  1949cited by this paper

• Photodynamic therapy induced vascular damage: an overview of experimental PDT

  2013cites this paper
• Mechanisms of action of phenanthroperylenequinones in photodynamic therapy (review).

  2003cites this paper
• Inhibition of phthalocyanine-sensitized photohemolysis of human erythrocytes by polyphenolic antioxidants: description of quantitative structure-activity relationships.

  2000cites this paper
• New potent sensitizers for photodynamic therapy: 21-oxaporphyrin, 21-thiaporphyrin and 21,23-dithiaporphyrin induce extensive tumor necrosis

  1999cites this paper
• Modulation of erythrocyte photohemolysis rate by glutathione reductase inactivating alkylating agents

  1998cites this paper
• The new sensitizing agents for photodynamic therapy: 21-selenaporphyrin and 21-thiaporphyrin.

  1997cites this paper
• Chemical modification of normal tissue damage induced by photodynamic therapy.

  1996cites this paper
• Serine Conjugates of Chlorophyll and Bacteriochlorophyll: Photocytotoxicity in vitro and Tissue Distribution in Mice Bearing Melanoma Tumors

  1996cites this paper
• 5,20-BIS(4-Sulphophenyl)-10,15-Bis(2-Methoxy-4-Sulphophenyl)-21-Thiaporphyrin as a new Potent Sensitizer in Photodynamic Therapy

  1995cites this paper
• Protective effect of amphotericin B against lethal photodynamic treatment in yeast.

  1995cites this paper
• Fluorescence detection of tumors early diagnosis of microscopic lesions in preclinical studies

  1993cites this paper
• HOW DOES PHOTODYNAMIC THERAPY WORK?

  1992cites this paper
• Potentiation of photodynamic therapy in mice with recombinant human tumor necrosis factor-alpha.

  1991cites this paper
• Potentiation of photodynamic therapy in mice with recombinant human tumor necrosis factors-α

  1991cites this paper
• PRECLINICAL EXAMINATION OF FIRST and SECOND GENERATION PHOTOSENSITIZERS USED IN PHOTODYNAMIC THERAPY

  1991cites this paper